Paul Karon

There is a lot that private funders can do. Here’s one example: the WHO Foundation and ELMA’s move to preserve a network tracking the growing measles threat.

As research funding cuts take their toll, here's some good news: an effort to get to grips with a critical factor in nearly every brain disease, including dementia, epilepsy, schizophrenia and hundreds of others.

PEPFAR-related service disruptions have already resulted in nearly 100,000 deaths. The good news is that AIDS-related philanthropy has ticked up, but more is needed.

The late Microsoft cofounder took big swings to advance human knowledge. The Fund for Science and Technology, a recent entrant in the Allen funding ecosystem, aims to continue that legacy.

The coalition of philanthropies involved in Humanity AI want to ensure that fundamental human concerns remain central to AI's future.

The longtime Nvidia board member and his wife recently gave $100 million to the University of Texas at Austin.

For the last five years, Break Through Cancer has been getting results through a deliberate, team-oriented approach to funding and researching cancer. It’s a model that might help tackle other biomedical challenges.

Private equity veteran Will Thorndike created the Cromwell Harbor Foundation to foster the careers of innovative, cross-disciplinary scholars.

A set of heavyweight grantmakers is backing Humanity AI to ensure the technology benefits society. Its first round of grants offers a window into its strategy.